pandemic
Novavax vaccine should be available from February 21st
The Novavax corona vaccine will be available in Germany from the end of February. Photo: Alastair Grant/AP/dpa
© dpa-infocom GmbH
The wait is over: the Novavav vaccine is to be vaccinated in Germany from the end of February. The agent was recently approved as the fifth corona vaccine in the EU.
Corona vaccinations with the preparation from the US manufacturer Novavax are expected to start in Germany at the end of February.
The first delivery of 1.75 million doses should be available from February 21, as Federal Minister of Health Karl Lauterbach said on Friday with reference to company information in Berlin. Exact dates for another 3.25 million doses that have been purchased have not yet been determined. He hopes for delivery in February.
Good effectiveness expected
Lauterbach explained that the preparation, which is “quasi an inactivated vaccine”, should be particularly available to those who prefer this type of vaccination. He himself could not assess the value of the Omicron variant well. But he assumes that the vaccine should work well. Vaccinations with it would be recommended.
Two doses are injected about three weeks apart. It is a protein vaccine – it is therefore based on a different technology than the previously available corona preparations. The effectiveness for protection against symptomatic infections was given by the EU medicines authority EMA at around 90 percent. Experts pointed out that not as much is known about the new vaccine as about the other preparations that have been in widespread use for some time.